Results 521-540 of 1,244,993 for in 'Dáil debates' OR (speaker:Rory O'Hanlon OR speaker:Peter Fitzpatrick OR speaker:Seán Sherlock OR speaker:Joe McHugh OR speaker:Aindrias Moynihan OR speaker:Cathal Berry OR speaker:Micheál Martin OR speaker:Helen McEntee OR speaker:Matt Carthy OR speaker:Louise O'Reilly OR speaker:Johnny Mythen OR speaker:Michael Healy-Rae OR speaker:Catherine Connolly OR speaker:Pearse Doherty OR speaker:Michael McGrath OR speaker:Jim O'Callaghan OR speaker:Thomas Gould OR speaker:Seán Ó Fearghaíl OR speaker:Pauline Tully OR speaker:Dara Calleary OR speaker:Pat Buckley OR speaker:Imelda Munster OR speaker:Alan Farrell OR speaker:Steven Matthews OR speaker:Thomas Pringle OR speaker:Pádraig Mac Lochlainn OR speaker:Aengus Ó Snodaigh OR speaker:Pádraig O'Sullivan OR speaker:Seán Ó Fearghaíl4 OR speaker:Aengus Ó Snodaigh17 OR speaker:Aengus Ó Snodaigh13 OR speaker:Aengus Ó Snodaigh10 OR speaker:Catherine Martin OR speaker:Aengus Ó Snodaigh08 OR speaker:Aengus Ó Snodaigh3 OR speaker:Aengus Ó Snodaigh05 OR speaker:Denis Naughten OR speaker:Mark Ward OR speaker:Dessie Ellis OR speaker:Maurice Quinlivan OR speaker:Bernard Durkan OR speaker:Róisín Shortall OR speaker:John McGuinness OR speaker:Chris Andrews OR speaker:Martin Kenny OR speaker:Jack Chambers OR speaker:Joe O'Brien OR speaker:Catherine Murphy OR speaker:Bernard Durkan9 OR speaker:Anne Rabbitte OR speaker:Niamh Smyth OR speaker:Seán Haughey OR speaker:Rose Conway-Walsh OR speaker:Seán Canney OR speaker:Donnchadh Ó Laoghaire OR speaker:Charlie McConalogue OR speaker:Aengus Ó Snodaigh28 OR speaker:Mary Butler OR speaker:James Browne OR speaker:Bríd Smith OR speaker:Aengus Ó Snodaigh03 OR speaker:Aengus Ó Snodaigh06 OR speaker:Seán Ó Fearghaíl5 OR speaker:Ivana Bacik OR speaker:Aengus Ó Snodaigh09 OR speaker:Martin Heydon) in 'Committee meetings'
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: It is that dual diagnosis thing that they just will not do it.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: Am I right in thinking that if people go in somewhere with bipolar or whatever it might be to ask for treatment, they will often be told they need to get clean first?
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: It is a catch-22.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: They would be turned away.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Mairead Farrell: Apologies have been received from Deputy John Brady. As this is my first meeting as Cathaoirleach, I must make the following declaration in attend in accordance with Standing Order 104(3)(a). Dearbhaím go sollúnta go ndéanfaidh mé, go cuí agus go dílis agus a mhéid is eol agus is cumas dom, oifig Chathaoirleach an Choiste um Chuntais Phoiblí a...
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Mairead Farrell: Inniu is é an príomhchainteoir ná an Teachta Ciarán Cannon. Beidh 15 nóiméad aige. The lead speaker today is Deputy Ciarán Cannon, who has 15 minutes. All other members will have ten minutes, but I will allow them back for a second round of questions. At 11 a.m., we will take a short break.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Mairead Farrell: Go raibh míle maith agat as sin. An dara chainteoir ná an Teachta Paul McAuliffe.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: I acknowledge the Cathaoirleach's new position. I have no doubt but that she will continue the good work of the previous Chair in chairing this committee and doing it in a cross-party way. Our work in this committee is very important, but so is the way we do our work. It is important and different from other committees. I acknowledge this point. I thank Mr. Gloster and all the team for...
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: I saw a figure regarding the outpatient waiting lists having been reduced by 50,000 people. Mr. Gloster is saying this is a real reduction rather than a validation exercise.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: Will Mr. Gloster repeat that figure?
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: I accept that point. The experience just shone a light on the outpatients waiting list for me.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: We do not know, but this may be the last or the second last meeting of this committee. It will certainly be the last meeting during this Dáil when Mr. Gloster will be before us anyway.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: I am very much cognisant of the volume of money associated with this hearing. We are talking about €23.5 billion. Many Government Departments could be folded into that figure. In 2019, the figure was €16 billion. Essentially, there has been a 46% increase in the funding of the HSE over the past four years, that is, the lifetime of this Government. In 60 seconds, can Mr....
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: I would love to explore that point more but I just do not have the time. Turning to the non-compliant procurement, this is the first thing we look at in this committee. The HSE estimated that the total expenditure on goods and services subject to procurement rules was €4.2 billion. Again, this amount is multiples of an entire Government Department in some cases. The idea that...
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: When the HSE did the self-assessed audit, there was a very significant percentage of either non-co-operation or where you could not identify the purchaser. The figure of 12% actually could be higher.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: Just to return to that point, Mr. Mulvany is saying the figure of 12% does include the 13% of invoices within the scope of the exercise where either the manager responsible could not be identified or where the manager failed to respond to the exercise. He is saying that 13% is deemed non-compliant and is included in the 12%.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: Will the C and AG confirm that?